GlyTherix is thrilled to be invited to speak at the AusBiotech 2024 National Conference.
In a session titled “The rise of radiopharmaceuticals: How Australian biotech is at the forefront of this resurgence” GlyTherix CEO, Dr Brad Walsh will be presenting with other session speakers on groundbreaking advancements in radiotherapies and radiopharmaceuticals and their impact on cancer diagnosis and treatment.
Don’t miss this opportunity to discover the evolving landscape of radiopharmaceuticals and uncover both the opportunities and challenges ahead.